A single-dose, open-label, randomized, four-treatment, four-way crossover dose finding study of Epinephrine intranasal spray in healthy volunteers
Latest Information Update: 13 Mar 2019
At a glance
- Drugs Epinephrine (Primary) ; Epinephrine
- Indications Anaphylaxis
- Focus Adverse reactions; Pharmacokinetics
Most Recent Events
- 07 Mar 2019 Status changed from active, no longer recruiting to completed, according to an INSYS Therapeutics, Inc media release.
- 09 Jan 2019 Pharmacokinetic results were presented in an INSYS Therapeutics media release.
- 09 Jan 2019 According to an INSYS Therapeutics media release, the company announced the results from this study.